
GK Daily Special Edition: Chasing the Clock — What the Longevity Industry Can Actually Deliver
There is a drug, pulled out of a soil sample from a remote Pacific island, that reliably makes mice live about a quarter longer. There is a diabetes injection, sitting in millions of American refrigerators right now, that just posted the first randomized evidence of slowing a biological aging marker in humans. And there is a company with three billion dollars in the bank that has never sold a product. Somewhere in that triangle is the real story of aging science, and somewhere in it is a very expensive fantasy.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.